- TCNNF), a leading and top-performing cannabis company in the United States, today announced its financial results for the three and 12 months ended December 31, 2019.
- Our fourth quarter results reflect our strong brand and customer loyalty, which were key factors in our success for the year.
- Despite recent developments surrounding COVID-19 and the uncertainty in the global economy, we see strong medical cannabis demand in our target markets and expect to continue maintaining our over 50% market share in Florida.
- The Company determined that share-based compensation expense for previously disclosed warrants was understated by approximately $15.0 million in the reported financial statements for the year ended December 31, 2018 .
Read full article: newcannabisventures.com